Reuters - Health Report

Click to View in Browser

Thursday, January 4, 2018

Monsanto wins support from 11 U.S. states in California cancer dispute

CHICAGO (Reuters) - Monsanto Co has won support from eleven U.S. states in its attempt to stop California from requiring cancer warnings on products containing glyphosate, ratcheting up a legal fight over the company's popular weed killer.

Air pollution around conception tied to birth defects

(Reuters Health) - - Women who breathe polluted air during the month right before or after they get pregnant may be more likely to have babies with birth defects, a U.S. recent study suggests.

Philippines fines Sanofi, suspends clearance for Dengvaxia

MANILA (Reuters) - The Philippines has fined Sanofi $2,000 and suspended clearance for the French drug maker's controversial dengue vaccine Dengvaxia, citing violations on product registration and marketing, its health secretary said on Thursday.

Novartis' Promacta receives FDA breakthrough designation for new indication

ZURICH (Reuters) - Novartis drug Promacta has received breakthrough therapy designation from the U.S. Food and Drug Administration for first-line treatment of severe aplastic anemia (SAA).

Australia to permit medicinal cannabis exports in bid to capture lucrative market

SYDNEY (Reuters) - Australia said on Thursday it planned to become the fourth country in the world to legalise medicinal marijuana exports in a bid to score a piece of the estimated $55 billion global market.

Heart benefit of moderate drinking greater in wealthy people

(Reuters Health) - - People who enjoy a few cocktails each week may be less likely to die from heart disease than people who rarely or never drink, especially if they’re rich, a Norwegian study suggests.

Click bait ads are tied to teen smoking

(Reuters Health) - - Teens who engage with online tobacco ads are more likely to start smoking than their peers who aren’t lured by digital marketing campaigns, a U.S. study suggests.

How alcohol damages stem cell DNA and increases cancer risk

LONDON (Reuters) - Drinking alcohol produces a harmful chemical in the body which can lead to permanent genetic damage in the DNA of stem cells, increasing the risk of cancer developing, according to research published on Wednesday.

Momenta, Mylan plan trial of biosimilar to Regeneron eye drug

(Reuters) - Momenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc's blockbuster eye drug Eylea in the first half of this year, the two companies said on Wednesday.

FDA issues recall on J&J heart device

(Reuters) - The U.S. Food and Drug Administration on Tuesday issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve, following a recall by the company in June.